Recapitulating orthotopic tumor model through establishment of a parotid gland tumor with lung metastasis using HeLa cell injection into nude mice

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 701-708

  Park, Young Wook ^a   Kim, Seong Gon ^a   Choi, Je Yong ^b   Lee, Suk Keun ^a  

^a Gangneung Wonju National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Orthotopic tumor model; Salivary adenoid cystic carcinoma; Vascular metastasis; VEGF signaling pathways

Indexed keywords

ANGIOGENIC FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; HELA CELL; LUNG METASTASIS; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PAROTID GLAND; PAROTID GLAND TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TUMOR; SUBCUTANEOUS TISSUE; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, ADENOID CYSTIC; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HELA CELLS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PAROTID NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77349119366     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000687     Document Type: Article

References (33)

1. Hashitani S, Urabe M, Zushi Y, Segawa E, Okui S and Sakurai K: Establishment of nude mouse transplantable model of a human adenoid cystic carcinoma of the oral floor showing metastasis to the lymph node and lung. Oncol Rep 17: 67-72, 2007.
2. Fidler IJ: Seed and soil revisited. Contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin Nor Amer 10: 257-269, 2001.
3. Liotta LA and Kohn EC: The microenvironment of the tumour-host interface. Nature 411: 375-379, 2001.
4. Tseng W, Leong X and Engleman E: Orthotopic mouse model of colorectal cancer. J Vis Exp 10: 484, 2007.
5. Myers JN, Holsinger CH, Jasser SA, Bekele BN and Fidler IJ: An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 8: 293-298, 2002.
6. Kim S, Park YW, Schiff BA, et al: An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice. Clin Cancer Res 11: 1713-1721, 2005.
7. Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M and McKeehan WL: Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in human malignant salivary gland tumours. J Pathol 178: 429-436, 1996.
8. Nagel H, Laskawi R, Wahlers A and Hemmerlein B: Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2 and -3 in benign and malignant tumours of the salivary gland. Histopathol 44: 222-231, 2004.
9. Knox SM and Hoffman MP: Salivary gland development and regeneration. In: Salivary Diagnostics. Wong DT (ed). Wiley-Blackwell, Ames, pp6-7, 2008.
10. Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE and Driemel O: Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 53: 567-577, 2008.
11. Kim JW, Kim HP, Im SA, et al: The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines. Cancer Lett 272: 296-306, 2008.
12. Perrotte P, Matsumoto T, Inoue K, et al: Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 5: 257-264, 1999.
13. Price JE: Xenograft models in immunodeficient animals. Metastasis Research Protocols. Vol 2. Brooks SA and Schumacher U (ed). Humana Press, Totowa, pp205-213, 2001.
14. Yoneda J, Kuniyasu H, Crispens MA, et al: Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 90: 447-454, 1998.
15. Kim SG, Chae CH, Cho BO, et al: Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4. J Oral Pathol Med 35: 37-45, 2006.
16. Fidler IJ: Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5: 29-49, 1986.
17. Cui ZY, Park MJ, Lee J, et al: Modest anti-cancer activity of a bile acid acylated heparin derivative in a PC14PE6 induced orthotopic lung cancer model. Cancer Res Treat 41: 80-86, 2009.
18. Nakajima M, Morikawa K, Fabra A, Bucana CD and Fidler IJ: Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890-1898, 1990.
19. Myoken Y, Myoken Y, Okamoto T, Sato JD and Takada K: Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and bFGF in oral squamous cell carcinoma (SCC). J Oral Pathol Med 23: 451-456, 1994.
20. Hase T, Kawashiri S, Tanaka A, et al: Correlation of basic fibroblast growth factor expression with the invasion and the prognosis of oral squamous cell carcinoma. J Oral Pathol Med 35: 136-139, 2006.
21. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R and Rusnati M: Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16: 159-178, 2005.
22. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA and Elner VM: Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
23. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992.
24. Soufla G, Sifakis S and Spandidos DA: FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium. Cancer Lett 259: 146-155, 2008.
25. Kharchenko MV, Aksyonov AA, Melikova MM and Kornilova ES: Epidermal growth factor (EGF) receptor endocytosis is accompanied by reorganization of microtubule system in HeLa cells. Cell Biol Int 31: 349-359, 2007.
26. Kizaka-Kondoh S, Sato K, Tamura K, Nojima H and Okayama H: Raf-1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor. Mol Cell Biol 12: 5078-5086, 1992.
27. Shen L, Shui Y, Wang X, et al: EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy. BMC Cancer 8: 232, 2008.
28. Bikfalvi A, Klein S, Pintucci G and Rifkin DB: Biological roles of fibroblast growth factor-2. Endocr Rev 18: 26-45, 1997.
29. Powers CJ, McLeskey SW and Wellstein A: Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7: 165-197, 2000.
30. Azuma M, Yuki T, Motegi K and Sato M: Enhancement of bFGF export associated with malignant progression of human salivary gland cell clones. Int J Cancer 71: 891-896, 1997.
31. Patel VN, Rebustini IT and Hoffman MP: Salivary gland branching morphogenesis. Differentiation 74: 349-364, 2006.
32. Amin DN, Hida K, Bielenberg DR and Klagsbrun M: Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res 66: 2173-2180, 2006.
33. Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ and Fidler IJ: Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice. Clin Cancer Res 9: 1200-1210, 2003.